209 related articles for article (PubMed ID: 10414736)
1. Treatment outcome with adjuvant and salvage irradiation after radical prostatectomy for prostate cancer.
Vicini FA; Ziaja EL; Kestin LL; Brabbins DS; Stromberg JS; Gonzalez JA; Martinez AA
Urology; 1999 Jul; 54(1):111-7. PubMed ID: 10414736
[TBL] [Abstract][Full Text] [Related]
2. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
[TBL] [Abstract][Full Text] [Related]
3. A comparison of external beam radiation therapy versus radical prostatectomy for patients with low risk prostate carcinoma diagnosed, staged, and treated at a single institution.
Martinez AA; Gonzalez JA; Chung AK; Kestin LL; Balasubramaniam M; Diokno AC; Ziaja EL; Brabbins DS; Vicini FA
Cancer; 2000 Jan; 88(2):425-32. PubMed ID: 10640977
[TBL] [Abstract][Full Text] [Related]
4. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
[TBL] [Abstract][Full Text] [Related]
5. Nonrandomized comparison of surgery with and without adjuvant pelvic irradiation for patients with pT3N0 adenocarcinoma of the prostate.
Petrovich Z; Lieskovsky G; Langholz B; Huberman M; Streeter O; Skinner DG
Am J Clin Oncol; 2001 Dec; 24(6):537-46. PubMed ID: 11801750
[TBL] [Abstract][Full Text] [Related]
6. Treatment results of adjuvant radiotherapy and salvage radiotherapy after radical prostatectomy for prostate cancer.
Wadasaki K; Kaneyasu Y; Kenjo M; Matsuura K; Murakami Y; Hashimoto Y; Ito K; Kiriu H; Ito A
Int J Clin Oncol; 2007 Feb; 12(1):37-41. PubMed ID: 17380439
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant and salvage radiation therapy after radical prostatectomy for adenocarcinoma of the prostate.
Catton C; Gospodarowicz M; Warde P; Panzarella T; Catton P; McLean M; Milosevic M
Radiother Oncol; 2001 Apr; 59(1):51-60. PubMed ID: 11295206
[TBL] [Abstract][Full Text] [Related]
8. Positive resection margin and/or pathologic T3 adenocarcinoma of prostate with undetectable postoperative prostate-specific antigen after radical prostatectomy: to irradiate or not?
Choo R; Hruby G; Hong J; Hong E; DeBoer G; Danjoux C; Morton G; Klotz L; Bhak E; Flavin A
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):674-80. PubMed ID: 11849789
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome of patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): effect of adjuvant radiotherapy.
Lee HM; Solan MJ; Lupinacci P; Gomella LG; Valicenti RK
Urology; 2004 Jul; 64(1):84-9. PubMed ID: 15245941
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy.
Kupelian PA; Elshaikh M; Reddy CA; Zippe C; Klein EA
J Clin Oncol; 2002 Aug; 20(16):3376-85. PubMed ID: 12177097
[TBL] [Abstract][Full Text] [Related]
11. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.
Kupelian PA; Katcher J; Levin HS; Klein EA
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811
[TBL] [Abstract][Full Text] [Related]
12. Salvage radiotherapy for biochemical recurrence after radical prostatectomy: a study of 62 patients.
Peyromaure M; Allouch M; Eschwege F; Verpillat P; Debré B; Zerbib M
Urology; 2003 Sep; 62(3):503-7. PubMed ID: 12946755
[TBL] [Abstract][Full Text] [Related]
13. Improvement in relapse-free survival throughout the PSA era in patients with localized prostate cancer treated with definitive radiotherapy: year of treatment an independent predictor of outcome.
Kupelian PA; Buchsbaum JC; Elshaikh MA; Reddy CA; Klein EA
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):629-34. PubMed ID: 14529766
[TBL] [Abstract][Full Text] [Related]
14. Comparison of surgery alone with surgery and adjuvant radiotherapy for pT3N0 prostate cancer.
Petrovich Z; Lieskovsky G; Stein JP; Huberman M; Skinner DG
BJU Int; 2002 Apr; 89(6):604-11. PubMed ID: 11942974
[TBL] [Abstract][Full Text] [Related]
15. Postoperative radiotherapy in 423 patients with pT3N0 prostate cancer.
Petrovich Z; Lieskovsky G; Langholz B; Jozsef G; Streeter OE; Skinner DG
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):600-9. PubMed ID: 12062603
[TBL] [Abstract][Full Text] [Related]
16. Preirradiation PSA predicts biochemical disease-free survival in patients treated with postprostatectomy external beam irradiation.
Crane CH; Rich TA; Read PW; Sanfilippo NJ; Gillenwater JY; Kelly MD
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):681-6. PubMed ID: 9336150
[TBL] [Abstract][Full Text] [Related]
17. Comparison of adjuvant versus salvage radiotherapy policies for postprostatectomy radiotherapy.
Hagan M; Zlotecki R; Medina C; Tercilla O; Rivera I; Wajsman Z; Neulander EZ
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):329-40. PubMed ID: 15145145
[TBL] [Abstract][Full Text] [Related]
18. Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above.
Kupelian PA; Buchsbaum JC; Elshaikh M; Reddy CA; Zippe C; Klein EA
Cancer; 2002 Dec; 95(11):2302-7. PubMed ID: 12436435
[TBL] [Abstract][Full Text] [Related]
19. Long-term results of three-dimensional conformal adjuvant and salvage radiotherapy after radical prostatectomy.
Tsien C; Griffith KA; Sandler HM; McLaughlin P; Sanda MG; Montie J; Reddy S; Hayman JA
Urology; 2003 Jul; 62(1):93-8. PubMed ID: 12837430
[TBL] [Abstract][Full Text] [Related]
20. Postoperative adjuvant and salvage radiotherapy for prostate cancer: impact on freedom from biochemical relapse and survival.
Pacholke HD; Wajsman Z; Algood CB; Neulander EZ; Morris CG; Zlotecki RA
Urology; 2004 Nov; 64(5):982-6. PubMed ID: 15533490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
